⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3225512 | 0.71 | — | — | |
| SCHEMBL7905677 | 0.59 | — | — | |
| SCHEMBL2370770 | 0.57 | — | — | |
| SCHEMBL7051003 | 0.55 | — | — | |
| SCHEMBL3230295 | 0.55 | — | — | |
| SCHEMBL11254280 | 0.54 | — | — | |
| SCHEMBL2746231 | 0.54 | — | — | |
| SCHEMBL5846773 | 0.53 | — | — | |
| SCHEMBL19064595 | 0.52 | — | — | |
| SCHEMBL19386117 | 0.52 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3883928-A1 | GLP-1R AGONISTS AND USES THEREOF | Qilu Regor Therapeutics Inc. (CN) | 2021-09-29 | — | — | EP | disclosed |